BioPatrika - Bridging Science, Society, and Success

Headlines

All

FDA Approves Kresladi: First Gene Therapy for Rare Immune Disorder LAD-I

Regulatory Biopatrika News Desk - March 27, 2026

The U.S. FDA has approved Kresladi from Rocket Pharmaceuticals for patients with Leukocyte Adhesion Deficiency Type I (LAD-I), marking...

CDSCO Flags 4 Spurious Drugs and 194 Substandard Medicines in February 2026

Regulatory Biopatrika News Desk - March 27, 2026

CDSCO Flags Spurious and Substandard Drugs in Nationwide Quality Check In a routine but critical surveillance exercise, India’s apex drug...

Two Rare Keelback Snake Species Recorded in India

Science News Biopatrika News Desk - March 27, 2026

Rare Snake Species Discovered in India: Scientists Extend Known Range from Myanmar In a significant boost to India’s biodiversity records,...

Latest Opportunities in Life Sciences (March 27, 2026) | BoiPatrika

Career opportunities Biopatrika News Desk - March 27, 2026

body { font-family: Arial, sans-serif; } h1 { font-size: 24px; margin-bottom: 10px; } p { font-size: 14px; color: #444; } h2 {...

From Ulcers to Cancer: The Story Behind the Discovery of a Bacterial Cancer Protein

Science News Biopatrika News Desk - March 27, 2026

Discovery of CagA: How Helicobacter pylori Protein Drives Gastric Cancer In the early 1980s, the discovery of Helicobacter pylori transformed...

Dopamine, Rotenone, and α-Synuclein: A Molecular Tale of Phase Separation and Toxicity

Researcher Spotlight Biopatrika News Desk - March 27, 2026

Dopamine and Rotenone Drive Toxic Protein Changes in Parkinson’s Disease Study Research Summary: Dopamine and rotenone both accelerate α-synuclein (α-Syn)...

Career as a Computational Biologist – Suryanarayanan Venkatesan, PhD

Computational Scientist Biopatrika News Desk - March 27, 2026

Career as a Computational Biologist | Jobs, Skills & Industry Insights | Biopatrika Career Konnect brings forward diverse career journeys...

Latest Biotech Jobs, PhD & Fellowships (March 26, 2026) | BioPatrika

Career opportunities Biopatrika News Desk - March 26, 2026

body { font-family: Arial, sans-serif; } h1 { font-size: 24px; margin-bottom: 10px; } p { font-size: 14px; color: #444; } h2 {...

Immunogenicity Risk Assessment Drives Smarter and Safer Drug Development | EpiVax

Regulatory Biopatrika News Desk - March 26, 2026

Smarter Drug Development: How Early Immunogenicity Risk Assessment Is Transforming Biologics In the high-stakes world of drug development, one unexpected...